Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Elliott Boulding currently holds 106,713 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Elliott Boulding has been a net seller of PTCT stock. They have purchased $0 and sold $26.0M worth of shares.
Mark Elliott Boulding's most recent insider trade was on Nov 17, 2025, when they sold 2,812 shares at $25.69 per share.
Mark Elliott Boulding serves as Executive at PTC THERAPEUTICS, INC. (PTCT). They have executed 172 insider transactions totaling $26.0M over their tenure at the company.
Mark Elliott Boulding holds the position of Executive at PTC THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Mark Elliott Boulding has shown a selling trading pattern, with $0 in total purchases and $26.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Elliott Boulding was on Apr 17, 2023, when they sold $3.0M worth of PTCT shares. This transaction involved 58,631 shares at $51.42 per share.
Mark Elliott Boulding currently owns 106,713 shares of PTC THERAPEUTICS, INC. (PTCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Elliott Boulding's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Elliott Boulding has 172 Form 4 filings on record as an insider at PTC THERAPEUTICS, INC..
Set alerts for Mark Elliott Boulding and 40,000+ other insiders.